Fresh Tracks Therapeutics (FRTX) Q1 2024 Earnings

15MarConfirmed
Q4 2022
Q2 2023
Q3 2023
Q1 2024
-1.51
-0.9
-0.29
0.32

Details

Expected EPS
-1.51
Actual EPS
N/A
Surprise EPS
1.51
Surprise Percent
+100%

Description

Fresh Tracks Therapeutics (FRTX) will report earnings of for Q1 2024 on March 15, 2024.

0 Comments

Share your thoughts